EUCRISA Market: Current Analysis and Forecast (2023-2030)

Report Description

The EUCRISA market is expected to grow at a strong CAGR of around 6.5% during the forecast period owing to the rising cases of atopic eczema globally. For instance, according to the National Eczema Society in 2023, atopic eczema affects 1 in 5 children and 1 in 10 adults in the UK. In addition to this, the increasing product launches by pharmaceutical companies to find potential medicine, and rising research and development activities are also driving the EUCRISA market. Global pharmaceutical giants are leaving no stone unturned to showcase their potential for launching a new cure for eczema and expanding their portfolio. Several government initiatives are making significant approaches to find a better method of dealing with this condition. For example, the National Eczema Society keeps on building collaborations with companies to work for the welfare of society. It has partnered with Aspire Pharma, AbbVie, Dermal, Lilly, Sanofi, and others.

Some of the major players operating in the market are Pfizer Inc.; Abbvie Inc.; Sanofi; Bausch Health Companies Inc.; GSK plc.; LEO Pharma; Regeneron Pharmaceutical Inc.; Evelo Biosciences, Inc.; Cara Therapeutics; Bristol-Myers Squibb Company.

Insights Presented in the Report

“Amongst distribution channels, the online segment to grow with a significant rate in the forecast period”

Based on distribution channels, the market is bifurcated into online and offline. The online store segment is expected to grow with a significant rate owing to the ubiquity of digital media and the prevalence of social media marketing which has had a significant impact on the internet penetration of various countries, with the majority of sales being made through online media. Also, several new product launches for providing enhanced care to consumers are driving this segment’s growth. Thus, the online store segment is expected to grow at a significant rate in the upcoming years.

EUCRISA Market Report Coverage

“Amongst regions, North America region held a significant share in the year 2022”

North America held a significant share of the market in the year 2022. Several factors such as the availability of cutting-edge and innovative products, growing awareness of skin diseases, rising cases of atopic dermatitis in the region, and loaded investment in eczema drug discovery are driving the market in the region. For instance, as per the 2022 National Eczema Association, an estimated 16.5 million U.S. adults (7.3%) have atopic dermatitis that initially began at more than two years of age, with nearly 40% affected by moderate or severe disease. North America dominated the EUCRISA market among regions in the year 2022.

Reasons to buy this report:

• The study includes market sizing and forecasting analysis validated by authenticated key industry experts.
• The report presents a quick review of overall industry performance at one glance.
• The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolios, expansion strategies, and recent developments.
• Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.
• The study comprehensively covers the market across different segments.
• Deep dive regional level analysis of the industry.

Customization Options:

The global EUCRISA market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

Frequently Asked Questions (FAQ)

You can also purchase parts of this report. Do you want to check out a section wise
price list?

Get in touch with team

Research Methodology

Research Methodology for the EUCRISA Market Analysis (2023-2030)

Analyzing the historical market, estimating the current market, and forecasting the future market of the global EUCRISA market were the three major steps undertaken to create and analyze the adoption of EUCRISA in major regions globally. Exhaustive secondary research was conducted to collect the historical market numbers and estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were also conducted, with industry experts across the value chain of the global EUCRISA market. Post assumption and validation of market numbers through primary interviews, we employed a top-down/bottom-up approach to forecasting the complete market size. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments of the industry pertains to. Detailed methodology is explained below:

Analysis of Historical Market Size

Step 1: In-Depth Study of Secondary Sources:

Detail secondary study was conducted to obtain the historical market size of the EUCRISA market through company internal sources such as annual reports & financial statements, performance presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database, and other credible publications.

Step 2: Market Segmentation:

After obtaining the historical market size of the EUCRISA market, we conducted a detailed secondary analysis to gather historical market insights and share for different segments and sub-segments for major regions. Major segments are included in the report as distribution channel, and region. Further country-level analyses were conducted to evaluate the overall adoption of testing models in that region.

Step 3: Factor Analysis:

After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size of the EUCRISA market. Further, we conducted factor analysis using dependent and independent variables such as distribution channel, and region of the EUCRISA market. A thorough analysis was conducted for demand and supply-side scenarios considering top partnerships, mergers and acquisitions, business expansion, and product launches in the EUCRISA market sector across the globe.

Current Market Size Estimate & Forecast

Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the global EUCRISA market, and market shares of the segments. All the required percentage shares split, and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.

Estimation & Forecasting: For market estimation and forecast, weights were assigned to different factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e., the top-down/bottom-up approach were applied to arrive at the market forecast for 2030 for different segments and sub-segments across the major markets globally. The research methodology adopted to estimate the market size encompasses:

• The industry’s market size, in terms of revenue (USD) and the adoption rate of the EUCRISA market across the major markets domestically
• All percentage shares, splits, and breakdowns of market segments and sub-segments
• Key players in the global EUCRISA market in terms of products offered. Also, the growth strategies adopted by these players to compete in the fast-growing market

Market Size and Share Validation

Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, Regional Head, Country Head, etc.) across major regions. Primary research findings were then summarized, and statistical analysis was performed to prove the stated hypothesis. Inputs from primary research were consolidated with secondary findings, hence turning information into actionable insights.

Split of Primary Participants in Different Regions

Market Engineering

The data triangulation technique was employed to complete the overall market estimation and to arrive at precise statistical numbers for each segment and sub-segment of the global EUCRISA market. data was split into several segments & sub-segments post studying various parameters and trends in the areas of the distribution channel, and region in the global EUCRISA market.

The main objective of the Global EUCRISA Market Study

The current & future market trends of the global EUCRISA market were pinpointed in the study. Investors can gain strategic insights to base their discretion for investments on the qualitative and quantitative analysis performed in the study. Current and future market trends determined the overall attractiveness of the market at a regional level, providing a platform for the industrial participant to exploit the untapped market to benefit from a first-mover advantage. Other quantitative goals of the studies include:

• Analyze the current and forecast market size of the EUCRISA market in terms of value (USD). Also, analyze the current and forecast market size of different segments and sub-segments
• Segments in the study include areas of distribution channel, and region Define and analyze the regulatory framework for the EUCRISA industry
• Analyze the value chain involved with the presence of various intermediaries, along with analyzing customer and competitor behaviors of the industry
• Analyze the current and forecast market size of the EUCRISA market for the major region
• Major countries of regions studied in the report include Asia Pacific, Europe, North America, and the Rest of the World
• Company profiles of the EUCRISA market and the growth strategies adopted by the market players to sustain in the fast-growing market
• Deep dive regional level analysis of the industry

You can also purchase parts of this report. Do you want to check out a section wise
price list?

Get in touch with team